| (210) | Number of the EPO application | 20734337 |
| (220) | Filing date of the EPO application | 2020.06.18 |
| (80) | EPO patent specification publication (B) | EPB nr. 04/2024, 2024.01.24 |
| (110) | EPO patent number | 3986862 |
| (21) | Number of the application | e 2022 0465 |
| (71) | Name(s) of applicant(s), code of the country | Abliva AB, SE; |
| (72) | Name(s) of inventor(s), code of the country | HANSSON Magnus Joakim, SE;
GRÖNBERG Alvar, SE;
ELMÉR Mats Eskil, SE;
FARMERY Mark Richard, SE;
MOSS Steven James, GB;
WEBSTER Lee Robert, GB;
GREGORY Matthew Alan, GB; |
| (73) | Name(s) of owner(s), code of the country | Abliva AB, SE; |
| (54) | Title of the invention | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07C 327/30 (2006.01.01); A61K 31/16 (2006.01.01); A61P 3/00 (2006.01.01); A61P 25/16 (2006.01.01) |
| (19) | Country | SE |
| (41) | Date of publication of the application | 2022.05.31 |
| (30) | Priority | PA201970382, 2019.06.19, DK; PA201970383, 2019.06.19, DK; PA201970384, 2019.06.19, DK |
| (86) | International application | PCT/EP2020/066923, 2020.06.18 |
| (87) | International publication | WO 2020/254484, 2020.12.24 |